12.10
price down icon3.66%   -0.46
pre-market  Pre-mercato:  11.94   -0.16   -1.32%
loading

Dyne Therapeutics Inc Azioni (DYN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
2.17%
69.16
67.69 62.27 66.74 45.46
Operating Income/Loss
2.17%
-69.16
-67.69 -62.27 -66.74 -45.46
Income/Loss From Continuing Operations Before Tax
1.48%
-65.65
-66.64 -60.21 -64.90 -44.19
Income/Loss From Continuing Operations After Tax
1.48%
-65.65
-66.64 -60.21 -64.90 -44.19
Net Income/Loss
1.48%
-65.65
-66.64 -60.21 -64.90 -44.19
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Earnings Per Share
25.69%
-0.81
-1.09 -0.99 -1.08 -0.78
Diluted Earnings Per Share
25.69%
-0.81
-1.09 -0.99 -1.08 -0.78
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$65.71
price down icon 3.01%
$19.31
price down icon 3.11%
$32.82
price down icon 1.59%
$24.61
price down icon 2.57%
$94.50
price down icon 2.85%
biotechnology ONC
$224.73
price down icon 3.65%
Capitalizzazione:     |  Volume (24 ore):